Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advisory Committee Dispute Resolution Requests To Be Decided In 30 Days

This article was originally published in The Tan Sheet

Executive Summary

Appeals for dispute resolution between a product sponsor and FDA, including requests for advisory committees to hear disputes, will be approved or denied by the agency within 30 days for user fee products, a March 19 draft guidance indicates.

You may also be interested in...



Dispute resolution

FDA announces availability of final guidance, "Formal Dispute Resolution: Appeals Above the Division Level," in the Federal Register March 7. The guidance provides procedures that will be adopted by the Center for Drug Evaluation & Research for resolving scientific and procedural disputes that cannot be settled at the division level. The document, describing methods for formally appealing such disputes to the office or center level, bears few changes from a draft version published in March (1"The Tan Sheet" March 22, 1999, p. 18)

Dispute resolution

FDA announces availability of final guidance, "Formal Dispute Resolution: Appeals Above the Division Level," in the Federal Register March 7. The guidance provides procedures that will be adopted by the Center for Drug Evaluation & Research for resolving scientific and procedural disputes that cannot be settled at the division level. The document, describing methods for formally appealing such disputes to the office or center level, bears few changes from a draft version published in March (1"The Tan Sheet" March 22, 1999, p. 18)

Dispute resolution

FDA announces availability of final guidance, "Formal Dispute Resolution: Appeals Above the Division Level," in the Federal Register March 7. The guidance provides procedures that will be adopted by the Center for Drug Evaluation & Research for resolving scientific and procedural disputes that cannot be settled at the division level. The document, describing methods for formally appealing such disputes to the office or center level, bears few changes from a draft version published in March (1"The Tan Sheet" March 22, 1999, p. 18)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel